Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $5.50 | Prev. Close $5.00 | Circuit Range N/A |
Day Range $5.50 - $5.58 | Year Range $0.26 - $19.81 | Volume 645 |
Average Traded $5.54 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-26 | $4.86 | $5.00 | +14.03% |
11-May-26 | $4.38 | $4.38 | +9.35% |
08-May-26 | $3.94 | $4.01 | -0.50% |
07-May-26 | $4.24 | $4.03 | -2.54% |
06-May-26 | $4.20 | $4.13 | -4.28% |
05-May-26 | $4.30 | $4.32 | -6.49% |
04-May-26 | $4.93 | $4.62 | -7.60% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?